The Use of Mesenchymal Stem Cells Immunomodulatory Potency to Promote Pancreatic Islet Cell Health of Type 1 Diabetes
Mia Aguilar Introduction. The chronic-autoimmune disease type 1 diabetes mellitus (T1D) affects millions of people worldwide with incident rates continuing to rise 3-4% every year over the past 30 years.1 Antigen Presenting Cells (APCs) presenting β cell peptides to autoreactive CD4+ T lymphocytes in the pancreatic lymph nodes. Attachment of…